Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder Cancer

Abstract

Increased VEGFR2 expression correlates with several features that predict progression of urothelial cancer, including disease stage and invasive phenotype. VEGF targeted therapy may enhance the efficacy of standard therapy for bladder cancer.